To examine our hypothesis that PiHL upregulation induces cytotoxic drug resistance in CRC cells, we treated SW480 and HCT116 cells with chemotherapeutic cytotoxic drugs now commonly used in clinical settings under either vector or PiHL overexpression conditions. This evidence concerns the gene PCAT1 and colorectal carcinoma.